Healthtech Startups

Urgence Docteurs is a French telehealth service offering on-demand video consultations and in-home doctor visits, available 24/7 with doctors registered with the medical board. It serves patients seeking general and specialist medical care, with home visits available in the Île-de-France region, and consultations reimbursable by the French social security system.

2 investors

Urgent Team operates a network of urgent care and walk-in medical centers offering treatment for non-emergency injuries and illnesses as well as occupational health services such as DOT physicals and employment health assessments. The company runs 80+ accredited centers, including rural health clinics, across Alabama, Arkansas, Georgia, Mississippi, and Tennessee.

2 investors

UrgentIQ provides an AI-native electronic medical record and practice management system designed specifically for urgent care centers, handling patient intake, clinical documentation, coding, and billing. The platform serves urgent care center staff and operators seeking to reduce administrative burden and improve patient outcomes.

2 investors

UV Angel manufactures ultraviolet light-based air treatment systems that reduce bacteria, viruses, and fungi in occupied indoor spaces. The company serves customers across all industries and provides a cloud-based software platform with IoT connectivity to monitor and manage air treatment performance across single units or entire fleets.

2 investors

Zener manufactures a ceiling-mounted far-UV disinfection device for operating rooms designed to reduce surgical site infections by increasing air changes and eliminating airborne bacteria during surgery. The device uses SafeRay technology (222 nm far-UV light) that provides bactericidal efficacy without the safety risks associated with traditional UV light.

2 investors

Vaderis develops a first-of-its-kind oral therapy for hereditary hemorrhagic telangiectasia (HHT), a rare vascular disease with no existing approved treatments. The company is led by scientists and clinicians focused on creating therapeutic options for patients with underserved rare diseases.

2 investors

VahatiCor is developing the A-FLUX Reducer System, an interventional device to treat coronary microvascular dysfunction, a condition affecting millions of patients—particularly women—who experience chest pain and cardiac symptoms despite normal standard angiography results. The company addresses a treatment gap for patients with coronary microvascular dysfunction who do not respond to medical management.

2 investors

Vālenz Health operates an integrated platform for self-funded/self-insured health plans, combining cost containment, care navigation, and member engagement to guide members to higher-value, lower-cost providers. It serves payers, plan sponsors/employers, providers, and patients in the U.S. healthcare benefits market.

2 investors

Vali provides scheduling and coordination software for home care agencies, confirming shift attendance, following up on missed clock-ins, and monitoring coverage around the clock to keep visits accurate and billing-ready. It handles caregiver engagement and shift management, and integrates with an agency's existing systems.

2 investors

Valiance Health develops healthcare analytics solutions built on academic research into healthcare delivery optimization.

2 investors

Validfor provides computerized system validation (CSV) software and consulting for the life sciences and pharmaceutical industry, covering validation management, data integrity, and quality assurance. It serves regulated companies needing to demonstrate compliance of their computerized systems.

2 investors

Valify provides purchased services expense management software for health systems, categorizing and cleansing accounts payable spend data to give visibility into purchased services spend and identify savings. It also offers a preferred supplier network (Valify Solutions Group) and advisory services to help healthcare providers reduce costs and manage contracts.

2 investors

Valisure is a private company that accepts investment from venture capital firms, family offices, and individual accredited investors.

2 investors

Valora Therapeutics is a biotech company developing antibody-lectin chimera (AbLec) therapeutics that target cell-surface glycans for immuno-oncology and immunotherapy applications. Its work builds on glycobiology and bioorthogonal chemistry research.

2 investors

Vanna Health provides community-based psychosocial rehabilitation for adults living with serious mental illness (SMI), using local pod support groups, physical clubhouses, and digital engagement. It aims to improve social and clinical outcomes and lower the total cost of care by supporting engagement with preventive clinical care.

2 investors

VARYTEX develops software for kampo (traditional Chinese/Japanese herbal medicine) diagnosis support and pre-symptomatic ("mibyo") health, and provides kampo business consulting plus medical and health content and marketing services. The company works to standardize kampo theory and promote its appropriate use within medical settings in Japan.

2 investors

Vatica Health develops software solutions for primary care physicians, health plans, and providers to improve the Medicare Annual Wellness Visit and risk adjustment processes. The platform enhances care quality, financial performance, and compliance while helping care teams work together to achieve better patient outcomes.

2 investors

Vault Workforce Screening provides background checks, drug and alcohol testing, and occupational health screening services for employers and healthcare organizations. The company operates as a Consumer Reporting Agency and third-party administrator specializing in workforce screening with compliance expertise and direct Medical Review Officer support.

2 investors

Vault Dragon builds electronic medical record (EMR), hospital information system (HIS), and healthcare data software for clinics and healthcare providers, with plans for a medical supplies marketplace and AI-driven predictive analytics. The company operates across Asia, including Singapore, China, Thailand, Cambodia, Malaysia, and Vietnam.

2 investors

Vedana Therapeutics develops next-generation biologic medicines for migraine prevention, targeting PACAP and CGRP-independent pathways to address unmet needs in patients inadequately controlled by current therapies. The company focuses on the neurological and pharmaceutical sectors to serve the global migraine patient population.

2 investors

Beidenmedical is a medical device supplier and distributor serving healthcare dealers and partners in China, operating a digital supply and services platform for medical equipment distribution.

2 investors

Veera develops supplements and wellness products designed specifically for women's biology and hormones, with formulations tested on female physiology. The company focuses on evidence-backed, clean, plant-based products for the women's health market.

2 investors

Velocity operates dedicated and embedded clinical research sites across the United States, providing the staff, equipment, study contracting, regulatory documentation, and business development support needed to run clinical trials. It partners with physician groups, independent practices, and health centers to add research capabilities and covers a wide range of therapeutic areas.

2 investors

Venova Medical develops the Velocity percutaneous arteriovenous fistula system, a minimally invasive medical device designed to create vascular access for hemodialysis patients more efficiently than traditional surgical methods. The system addresses barriers to AVF creation and maturation, targeting patients with chronic kidney disease who require dialysis access.

2 investors